hyperlipoproteinemia type III

Search with Google Search with Bing
Information
Disease name
hyperlipoproteinemia type III
Disease ID
DOID:3145
Description
"A familial hyperlipidemia that has_material_basis_in by homozygous, compound heterozygous, or heterozygous mutation in the APOE gene on chromosome 19q13." [url:https\://omim.org/entry/617347]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00214604 Completed Phase 3 Type III Dysbetalipoproteinemia February 2005 February 2007
NCT00145431 Terminated Phase 3 Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. March 2005 December 2006
NCT03811223 Unknown status Phase 4 Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia August 2019 March 2021
Disase is a (Disease Ontology)
DOID:1168
Cross Reference ID (Disease Ontology)
MESH:D006952
Cross Reference ID (Disease Ontology)
MIM:617347
Cross Reference ID (Disease Ontology)
NCI:C34710
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:42569002
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0020479
Exact Synonym (Disease Ontology)
carbohydrate induced hyperlipemia
Exact Synonym (Disease Ontology)
familial hypercholesterolaemia with hyperlipaemia
Exact Synonym (Disease Ontology)
familial type 3 hyperlipoproteinemia
Exact Synonym (Disease Ontology)
Remnant hyperlipidemia
MeSH unique ID (MeSH (Medical Subject Headings))
D006952